In May of Shanghai, the grand industry event arrived as scheduled. At the 94th China International API, Intermediate, Packaging & Equipment Exhibition, Sichuan Xieli Pharmaceutical Co., Ltd. (hereinafter referred to as "Xieli Pharma") participated with its core product portfolio and innovative solutions, exploring new paths for the high-quality development of the pharmaceutical industry together with industry partners in a professional manner.
Centering on the core themes of CDMO, API and natural extracts, Xieli Pharma set up a professional booth at this exhibition, fully demonstrating its solid strength in pharmaceutical APIs, characteristic intermediates, natural extracts and customized CDMO services. The booth adopted the brand’s consistent blue and white main tone, matched with soft lighting and open negotiation areas, which not only highlights the rigor and professionalism of a pharmaceutical enterprise, but also creates a comfortable communication environment for on-site visitors.
As a professional enterprise in China’s pharmaceutical and health industry, Xieli Pharma spotlighted core product lines including bile acid series, citrus auratium series and camptothecin series, attracting numerous industry peers for on-site consultation.
· Bile Acid Series: With mature production processes and stable product quality, widely applied in hepatobiliary medicine and functional food sectors. Compliant with mainstream domestic and international regulatory standards including NMPA, FDA and EDQM, supporting customized production and quality research services.
· Citrus Auratium Series: Rooted in natural plant extraction and leveraging full industrial chain advantages, the product realizes whole-process management from raw material planting, extraction and purification to quality control, with purity and stability meeting mainstream global standards.
· Camptothecin Series: Specializing in oncology pharmaceutical intermediates, delivering high-quality key raw material support for downstream pharmaceutical enterprises via advanced synthesis technology and strict quality control systems.
In addition to the display of featured products, Xieli Pharmaceutical also focused on promoting its one-stop CDMO service platform. From process development and pilot scale-up to commercial production, it provides customers with full-process customized solutions for APIs and preparations, helping customers shorten R&D cycles, reduce production costs and accelerate product marketing.
From APIs and high-grade intermediates to formulation development and customized production, we have built a service system covering the entire pharmaceutical R&D chain to meet the diverse needs of customers at different stages. With a sound quality management system and rich experience in domestic and international certification, Xieli Pharmaceutical has become a trusted partner for many pharmaceutical enterprises at home and abroad.
During the exhibition, Xieli Pharmaceutical’s booth maintained high popularity. Industry customers, partners and experts from home and abroad came in an endless stream to conduct in-depth exchanges on product R&D, market trends, compliance policies and other topics. Our core team was also on site, engaging in face-to-face communication with new and existing customers to discuss cooperation opportunities, amid a vibrant negotiation atmosphere.
This API exhibition is not only a stage for Xieli Pharma to showcase its strength, but also an important opportunity for the company to strengthen exchanges and deepen cooperation with industry partners. Through interaction and communication with upstream and downstream enterprises, Xieli Pharma has further grasped the pulse of industry development and injected new impetus into subsequent business expansion and technological innovation.
The successful participation in the Shanghai API Exhibition is another concentrated strength display of Xieli Pharma, as well as a new starting point for the company to move toward higher-quality development. In the future, Xieli Pharmaceutical will continue to focus on its core pharmaceutical and health business, increase R&D investment, improve technical capabilities, and continuously optimize product structure and service system. It will repay customers with higher-quality products and more professional services, and contribute "the Power of Xieli" to promoting the innovative development of China's pharmaceutical industry!
